We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

40 hedge funds and large institutions have $45.7M invested in Faeth Therapeutics in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% more ownership

Funds ownership: 0% → 0.52% (+0.52%)

Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$11.6M
2
DM
Deerfield Management
New York
+$6.28M
3
BlackRock
BlackRock
New York
+$5.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.43M
5
AWG
Alpha Wave Global
New York
+$3.58M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$10.1M +$11.6M +34,627 New
DM
2
Deerfield Management
New York
$5.45M +$6.28M +18,750 New
BlackRock
3
BlackRock
New York
$4.83M +$5.57M +16,635 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.72M +$5.43M +16,235 New
AWG
5
Alpha Wave Global
New York
$3.1M +$3.58M +10,683 New
JP Morgan Chase
6
JP Morgan Chase
New York
$2.26M +$2.6M +7,782 New
MCM
7
Moore Capital Management
New York
$1.85M +$2.13M +6,375 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.71M +$1.96M +5,870 New
Tudor Investment Corp
9
Tudor Investment Corp
Connecticut
$1.65M +$1.9M +5,668 New
DFO
10
Duquesne Family Office
New York
$1.45M +$1.67M +5,000 New
Northern Trust
11
Northern Trust
Illinois
$1.19M +$1.37M +4,097 New
PVI
12
Pura Vida Investments
New York
$941K +$1.13M +3,368 New
State Street
13
State Street
Massachusetts
$854K +$984K +2,939 New
FG
14
Formula Growth
Quebec, Canada
$818K +$942K +2,814 New
Charles Schwab
15
Charles Schwab
California
$672K +$774K +2,312 New
Two Sigma Investments
16
Two Sigma Investments
New York
$670K +$772K +2,306 New
ZP
17
Zimmer Partners
New York
$668K +$770K +2,300 New
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$401K +$462K +1,380 New
DKCM
19
Davidson Kempner Capital Management
New York
$376K +$435K +1,300 New
SAM
20
Serengeti Asset Management
New York
$291K +$335K +1,000 New
MWNA
21
Marshall Wace North America
New York
$265K +$306K +914 New
Deutsche Bank
22
Deutsche Bank
Germany
$254K +$292K +872 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$205K +$235K +703 New
Bank of America
24
Bank of America
North Carolina
$202K +$234K +698 New
N
25
Nuveen
North Carolina
$179K +$206K +617 New
1
2

FTH Hedge Fund Activity: Q1 2021 in Review

40 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q1 2021, worth a combined $45.7M.

Buyers outnumbered sellers: 40 funds opened new FTH positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $11.6M.

  • 40 institutional investors held Faeth Therapeutics (FTH) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $45.7M of Faeth Therapeutics stock for Q1 2021.
  • 40 funds opened new Faeth Therapeutics positions in Q1 2021 and 0 closed out, a net change of +40 holders.
  • The largest Faeth Therapeutics buyer in Q1 2021 was Citadel Advisors, an estimated $11.6M added.

Based on aggregated 13F filings for Q1 2021.